Takii, Ami
Tanabe, Yukika
Li, Wenting
Shiomi, Hiroki
Inoue, Akane
Muramatsu, Fumitaka
Jia, Weizhen
Takakura, Nobuyuki
Funding for this research was provided by:
Japan Agency for Medical Research and Development (24ama221533h0001, 24ck0106727h0003)
Japan Society for the Promotion of Science (20H05698)
Ministry of Education, Culture, Sports, Science and Technology (JPMXP1323015484)
Article History
Received: 11 November 2024
Accepted: 5 May 2025
First Online: 14 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: NT recently established a start-up company, RevascularBio Co., Ltd., focusing on the clinical application of endothelial stem cells. All other authors declare that they have no competing interests.